title: Impact of antithymocyte globulin on the need for platelet transfusions during reduced-intensity conditioning administration before allogeneic stem cell transplantation.
authors: Angela
authors: A
authors: Granata
authors: Luca
authors: L
authors: Castagna
authors: Roberto
authors: R
authors: Crocchiolo
authors: Sabine
authors: S
authors: Fürst
authors: Jean
authors: J
authors: El Cheikh
authors: Claire
authors: C
authors: Oudin
authors: Patrick
authors: P
authors: Ladaique
authors: Claude
authors: C
authors: Lemarie
authors: Boris
authors: B
authors: Calmels
authors: Catherine
authors: C
authors: Faucher
authors: Christian
authors: C
authors: Chabannon
authors: Didier
authors: D
authors: Blaise
mesh_terms: D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006402:Hematologic Diseases / Q000601:surgery; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D017713:Platelet Transfusion / Q000706:statistics & numerical data*; D011183:Postoperative Complications / Q000139:chemically induced* / Q000628:therapy; D012189:Retrospective Studies; D013601:T-Lymphocytes; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000628:therapy; D019172:Transplantation Conditioning / Q000379:methods; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents